Bookmark

Add to MyYahoo RSS

Humalog, Insulin Lispro News

News on Humalog, Insulin Lispro (generic) continually updated from thousands of sources around the net.

Thursday Jul 24 | BioSpace

Adocia Reports Operational And Financial Results For The First Half Of 2014

Major clinical results reported on two formulations based on insulin Sound financial position with approximately EUR 16 million in cash at LYON, France-- --July 24, 2014-- Regulatory News: Adocia , a biotechnology company specialized in the development of 'best-in-class' medicines from already approved therapeutic proteins, announces today its ... (more)

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, France, World News, Lantus, Insulin Glargine (generic)

Thursday Jul 24 | The Washington Post

Eli Lilly Beats Quarterly Estimates on Diabetes Drug Sales

Eli Lilly & Co., the drugmaker experiencing a wave of sales losses as patents expire, reported second quarter profit that beat analysts' estimates with better than expected sales of its diabetes drug Humalog.

Comment?

Related Topix: Biotech, Medicine, Diabetes, Eli Lilly, Health, Healthcare Industry, Insulin (generic), Humulin, Novolin, Business News

Wed Jul 09, 2014

BioSpace

Adocia Announces Approval To Start A Phase IIa Clinical Study Of...

HinsBet's objective is to improve human insulin performance in a cost-effective way Phase IIa study will compare HinsBet to a fast-acting insulin analog and a regular human insulin in type 1 diabetic patients First Patient In planned for the first week of August Lyon, France, July 9th, 2014 - Adocia announced today that BfArM , the German ... (more)

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Adocia, France, World News,

Mon Jun 30, 2014

The Motley Fool

MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint?

Approval is a major event for MannKind, but the company still needs a commercial partner and the approved label for Afrezza doesn't do the product/company any particular favors.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Insulin (generic), Humulin, Novolin, Advanced Bionics, Medical Equipment, Healthcare Industry, Health, Lung Cancer, Diabetes

Fri Jun 27, 2014

Reuters

UPDATE 3-U.S. FDA approves MannKind's inhaled insulin, Afrezza

The U.S. Food and Drug Administration said on Friday it has approved MannKind Corp's inhaled insulin, Afrezza, capping an arduous journey for the company and its octogenarian founder, Alfred Mann.

Comment?

Related Topix: Food and Drug Administration, Biotech, MannKind, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Lung Cancer

•••
•••
•••
•••
•••
•••
•••